As of 11:47am ET
| -0.03 / -0.60%|
The 7 analysts offering 12-month price forecasts for Conatus Pharmaceuticals Inc have a median target of 11.00, with a high estimate of 26.00 and a low estimate of 4.00. The median estimate represents a +120.00% increase from the last price of 5.00.
The current consensus among 7 polled investment analysts is to Buy stock in Conatus Pharmaceuticals Inc. This rating has held steady since March, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.